Assault against respiratory syncytial virus: beginning of an era.
Abzug
M J
MJ
University of Colorado School of Medicine, Denver, USA.
D006801:Humans; D007116:Immunization, Passive; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000517:prevention & control; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012136:Respiratory Syncytial Viruses; D012141:Respiratory Tract Infections / Q000517:prevention & control
D016756:Immunoglobulins, Intravenous; C098685:respiratory syncytial virus immune globulin intravenous